236. Pseudohypoparathyroidism Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 3 /  Drugs : 3 - (DrugBank : 2) / Drug target genes : 18 - Drug target pathways : 23

Pseudohypoparathyroidism and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
IDDiseases (Sorted by score)Score
236Pseudohypoparathyroidism-
299Cystic fibrosis20.000
63Idiopathic thrombocytopenic purpura16.920
246Methylmalonic acidemia15.812
226Interstitial cystitis with Hunners ulcer13.600
265Lipodystrophy8.144
46Malignant rheumatoid arthritis7.511
13Multiple sclerosis/Neuromyelitis optica7.417
78Hypopituitarism7.287
96Crohn disease6.374
2Amyotrophic lateral sclerosis6.367
21Mitochondrial disease6.064
97Ulcerative colitis5.350
6Parkinson disease5.266
107Juvenile idiopathic arthritis1.611
162Pemphigoid1.188
56Behcet disease1.156
271Ankylosing spondylitis1.112
50Dermatomyositis1.067
191Werner syndrome1.000